Key result
Resistant hypertension affects ~26% of CKD patients, linked to older age, advanced CKD, and metabolic comorbidities.
Why the study?
Resistant arterial hypertension is common in patients with chronic kidney disease, but its prevalence and associated factors needed assessment in referral hospitals in Cameroon.
Population
194 patients over 18 years of age with hypertension and CKD stage 2-5 ND
Comparison
Patients with resistant arterial hypertension vs those without
Design
Cross-sectional analytical study
Authors
Loading...
Supports risk stratification in advanced CKD; leaves open need for longitudinal studies before changing practice.
Cross-Sectional (n=194)
Yes
Resistant arterial hypertension is highly prevalent (26.29%) among patients with CKD in Cameroon and is strongly associated with older age, advanced CKD, and traditional cardiovascular risk factors.
HM et al. (2022) conducted a cross-sectional in Chronic kidney disease and hypertension (n=194). Risk factors (age >60, CKD grade 5, diabetes, dyslipidemia, obesity, smoking) was evaluated on Prevalence of resistant arterial hypertension (RAH). The prevalence of resistant arterial hypertension among CKD patients was 26.29%, and was significantly associated with age >60 years, CKD grade 5, diabetes, dyslipidemia, obesity, and smoking.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: